gadobutrol
(ZPDFIIGFYAHNSK-UHFFFAOYSA-K)
Structure
- SMILES
- OCC(C(N1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CO)O.[Gd+3]
- Molecular Formula:
- C18H31GdN4O9
- Molecular Weight:
- 604.710
- Log P:
- -8.0766
- Hydrogen Bond Acceptor:
- 13
- Hydrogen Bond Donor:
- 3
- TPSA:
- 194.04
- CAS Number(s):
- 138071-82-6
Synonym(s)
1.
gadobutrol
2.
Gadovist
3.
Gd-DO3A-butriol
4.
gadolinium-DO3A-butriol
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Urticaria | FAERS: 827 Canada Vigilance: 102 | Canada Vigilance US FAERS | |
| 2 | Nausea | FAERS: 687 Canada Vigilance: 31 | Canada Vigilance SIDER US FAERS | |
| 3 | Vomiting | FAERS: 599 Canada Vigilance: 25 | Canada Vigilance SIDER US FAERS | |
| 4 | Pruritus | FAERS: 407 Canada Vigilance: 52 | Canada Vigilance US FAERS | |
| 5 | Erythema | FAERS: 236 Canada Vigilance: 33 | Canada Vigilance US FAERS | |
| 6 | Dizziness | FAERS: 125 Canada Vigilance: 9 | Canada Vigilance SIDER US FAERS | |
| 7 | Throat irritation | FAERS: 113 Canada Vigilance: 18 | Canada Vigilance US FAERS | |
| 8 | Sneezing | FAERS: 105 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 9 | Headache | FAERS: 93 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 10 | Contrast media reaction | FAERS: 74 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 11 | Flushing | FAERS: 71 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 12 | Chest discomfort | FAERS: 65 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 13 | Malaise | FAERS: 59 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 14 | Hypotension | FAERS: 57 | US FAERS | |
| 15 | Chest Pain | FAERS: 56 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 16 | Hypersensitivity | FAERS: 53 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 17 | Burning sensation | FAERS: 45 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 18 | Lip swelling | FAERS: 43 Canada Vigilance: 13 | Canada Vigilance US FAERS | |
| 19 | Cardiac Arrest | FAERS: 41 | US FAERS | |
| 20 | Contrast media allergy | FAERS: 40 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 21 | Feeling abnormal | FAERS: 40 | US FAERS | |
| 22 | Pain | FAERS: 40 | SIDER US FAERS | |
| 23 | Product use issue | FAERS: 39 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 24 | Tremor | FAERS: 34 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 25 | Syncope | FAERS: 33 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 26 | Chills | FAERS: 32 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | Dysphonia | FAERS: 31 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 28 | Rash erythematous | FAERS: 31 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 29 | Unresponsive to stimuli | FAERS: 30 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 30 | Abdominal Pain | FAERS: 29 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 31 | Pallor | FAERS: 28 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 32 | Presyncope | FAERS: 28 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 33 | Wheezing | FAERS: 28 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 34 | Anaphylactic shock | FAERS: 27 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 35 | Oropharyngeal discomfort | FAERS: 27 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 36 | Asthenia | FAERS: 26 | US FAERS | |
| 37 | Cyanosis | FAERS: 26 | US FAERS | |
| 38 | Fatigue | FAERS: 26 | US FAERS | |
| 39 | Retching | FAERS: 26 | US FAERS | |
| 40 | Swelling | FAERS: 25 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 41 | Tachycardia | FAERS: 25 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 42 | Drug ineffective | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 43 | Anxiety | FAERS: 22 | US FAERS | |
| 44 | Arthralgia | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Myalgia | FAERS: 22 | US FAERS | |
| 46 | Cold sweat | FAERS: 21 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 47 | Respiratory arrest | FAERS: 19 | US FAERS | |
| 48 | Respiratory distress | FAERS: 19 | US FAERS | |
| 49 | Adverse event | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Dysgeusia | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 51 | Alopecia | FAERS: 16 | US FAERS | |
| 52 | Bone pain | FAERS: 16 | US FAERS | |
| 53 | Shock | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 54 | Unevaluable event | FAERS: 16 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 55 | Visual Impairment | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 56 | Abdominal discomfort | FAERS: 15 | US FAERS | |
| 57 | Bradycardia | FAERS: 15 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 58 | Contrast media deposition | FAERS: 15 | US FAERS | |
| 59 | Gadolinium deposition disease | FAERS: 13 | US FAERS | |
| 60 | Palpitations | FAERS: 13 | SIDER US FAERS | |
| 61 | Peripheral swelling | FAERS: 13 | US FAERS | |
| 62 | Somnolence | FAERS: 13 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 63 | Agitation | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 64 | Disorientation | FAERS: 12 | US FAERS | |
| 65 | Feeling Cold | FAERS: 12 | US FAERS | |
| 66 | Muscle tightness | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 67 | Bronchospasm | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Eye irritation | FAERS: 11 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 69 | Nervousness | FAERS: 11 | US FAERS | |
| 70 | Nontherapeutic agent urine positive | FAERS: 11 | US FAERS | |
| 71 | Toxicity to various agents | FAERS: 11 | US FAERS | |
| 72 | Injection site erythema | FAERS: 10 | US FAERS | |
| 73 | Injection site pain | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 74 | Oropharyngeal pain | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 75 | Tinnitus | FAERS: 10 | US FAERS | |
| 76 | Vertigo | FAERS: 10 | SIDER US FAERS | |
| 77 | Angioedema | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 78 | Choking sensation | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 79 | Discomfort | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 80 | Head discomfort | FAERS: 9 | US FAERS | |
| 81 | Laryngospasm | FAERS: 9 | US FAERS | |
| 82 | Oral pruritus | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 83 | Skin tightness | FAERS: 9 | US FAERS | |
| 84 | Myocardial Infarction | FAERS: 8 | US FAERS | |
| 85 | Back Pain | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 86 | Incorrect route of drug administration | FAERS: 7 | US FAERS | |
| 87 | Musculoskeletal stiffness | FAERS: 7 | US FAERS | |
| 88 | Productive Cough | FAERS: 7 | US FAERS | |
| 89 | Respiratory Failure | FAERS: 7 | US FAERS | |
| 90 | Alveolitis | FAERS: 6 | US FAERS | |
| 91 | Aphasia | FAERS: 6 | SIDER US FAERS | |
| 92 | Asphyxia | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 93 | Asthma | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 94 | Conjunctivitis | FAERS: 6 | US FAERS | |
| 95 | Depressed Level of Consciousness | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 96 | Foaming at mouth | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 97 | Limb discomfort | FAERS: 6 | US FAERS | |
| 98 | Memory impairment | FAERS: 6 | US FAERS | |
| 99 | Nontherapeutic agent blood positive | FAERS: 6 | US FAERS | |
| 100 | Overdose | FAERS: 6 | US FAERS | |
| 101 | Pulmonary Fibrosis | FAERS: 6 | US FAERS | |
| 102 | Urinary Incontinence | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 103 | Vasculitis | FAERS: 6 | US FAERS | |
| 104 | Cardiovascular insufficiency | FAERS: 5 | US FAERS | |
| 105 | Contrast media toxicity | FAERS: 5 | US FAERS | |
| 106 | Dysarthria | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 107 | Dyspepsia | FAERS: 5 | US FAERS | |
| 108 | Emotional distress | FAERS: 5 | US FAERS | |
| 109 | Extravasation | FAERS: 5 | US FAERS | |
| 110 | Hypoxia | FAERS: 5 | US FAERS | |
| 111 | Injection site extravasation | FAERS: 5 | US FAERS | |
| 112 | Lethargy | FAERS: 5 | US FAERS | |
| 113 | Musculoskeletal chest pain | FAERS: 5 | US FAERS | |
| 114 | Nasal pruritus | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 115 | Nephrogenic Systemic Fibrosis | FAERS: 5 | US FAERS | |
| 116 | Polyneuropathy | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 117 | Product quality issue | FAERS: 5 | US FAERS | |
| 118 | Skin hypertrophy | FAERS: 5 | US FAERS | |
| 119 | Syringe issue | FAERS: 5 | US FAERS | |
| 120 | Accidental exposure to product | FAERS: 4 | US FAERS | |
| 121 | Aphonia | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Blood creatinine increased | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 123 | Blood heavy metal increased | FAERS: 4 | US FAERS | |
| 124 | Blood pressure immeasurable | FAERS: 4 | US FAERS | |
| 125 | Dehydration | FAERS: 4 | US FAERS | |
| 126 | Facial Pain | FAERS: 4 | US FAERS | |
| 127 | Hyperventilation | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 128 | Impaired work ability | FAERS: 4 | US FAERS | |
| 129 | Incorrect route of product administration | FAERS: 4 | US FAERS | |
| 130 | Infusion Site Extravasation | FAERS: 4 | US FAERS | |
| 131 | Injection site pruritus | FAERS: 4 | US FAERS | |
| 132 | Joint swelling | FAERS: 4 | US FAERS | |
| 133 | Maternal exposure during pregnancy | FAERS: 4 | US FAERS | |
| 134 | Mental impairment | FAERS: 4 | US FAERS | |
| 135 | Musculoskeletal discomfort | FAERS: 4 | US FAERS | |
| 136 | Nasal discomfort | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 137 | Neck Pain | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 138 | Photophobia | FAERS: 4 | US FAERS | |
| 139 | Product use in unapproved indication | FAERS: 4 | US FAERS | |
| 140 | Respiratory tract congestion | FAERS: 4 | US FAERS | |
| 141 | Restlessness | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 142 | Skin reaction | FAERS: 4 | US FAERS | |
| 143 | Tension Headache | FAERS: 4 | US FAERS | |
| 144 | Trismus | FAERS: 4 | US FAERS | |
| 145 | Weight decreased | FAERS: 4 | US FAERS | |
| 146 | Yawning | FAERS: 4 | US FAERS | |
| 147 | Accidental overdose | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 148 | Acidosis | FAERS: 3 | US FAERS | |
| 149 | Ageusia | FAERS: 3 | US FAERS | |
| 150 | Anaphylactoid Reaction | FAERS: 3 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 151 | Aspartate Aminotransferase Increased | FAERS: 3 | US FAERS | |
| 152 | Delirium | FAERS: 3 | US FAERS | |
| 153 | Dry skin | FAERS: 3 | US FAERS | |
| 154 | Ear discomfort | FAERS: 3 | US FAERS | |
| 155 | Epistaxis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 156 | Extra dose administered | FAERS: 3 | US FAERS | |
| 157 | Eyelids pruritus | FAERS: 3 | US FAERS | |
| 158 | Formication | FAERS: 3 | US FAERS | |
| 159 | Gamma-Glutamyltransferase Increased | FAERS: 3 | US FAERS | |
| 160 | General physical health deterioration | FAERS: 3 | US FAERS | |
| 161 | Incorrect dose administered by device | FAERS: 3 | US FAERS | |
| 162 | Incorrect dose administered | FAERS: 3 | US FAERS | |
| 163 | Inflammation | FAERS: 3 | US FAERS | |
| 164 | Injection site warmth | FAERS: 3 | US FAERS | |
| 165 | Lip pruritus | FAERS: 3 | US FAERS | |
| 166 | Medication Error | FAERS: 3 | US FAERS | |
| 167 | Mouth swelling | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 168 | No adverse event | FAERS: 3 | US FAERS | |
| 169 | Oromandibular dystonia | FAERS: 3 | US FAERS | |
| 170 | Pelvic Pain | FAERS: 3 | US FAERS | |
| 171 | Product complaint | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 172 | Pulmonary Hypertension | FAERS: 3 | US FAERS | |
| 173 | Quality of life decreased | FAERS: 3 | US FAERS | |
| 174 | Renal pain | FAERS: 3 | US FAERS | |
| 175 | Respiratory Depression | FAERS: 3 | US FAERS | |
| 176 | Seizure like phenomena | FAERS: 3 | US FAERS | |
| 177 | Vascular pain | FAERS: 3 | US FAERS | |
| 178 | Acne | FAERS: 2 | US FAERS | |
| 179 | Acute Coronary Syndrome | FAERS: 2 | US FAERS | |
| 180 | Acute myocardial infarction | FAERS: 2 | US FAERS | |
| 181 | Acute respiratory failure | FAERS: 2 | US FAERS | |
| 182 | Altered state of consciousness | FAERS: 2 | US FAERS | |
| 183 | Angina Pectoris | FAERS: 2 | US FAERS | |
| 184 | Anosmia | FAERS: 2 | US FAERS | |
| 185 | Atrial Fibrillation | FAERS: 2 | US FAERS | |
| 186 | Blood glucose increased | FAERS: 2 | US FAERS | |
| 187 | Blood heavy metal abnormal | FAERS: 2 | US FAERS | |
| 188 | Consciousness fluctuating | FAERS: 2 | US FAERS | |
| 189 | Crying | FAERS: 2 | US FAERS | |
| 190 | Deafness | FAERS: 2 | US FAERS | |
| 191 | Diplopia | FAERS: 2 | US FAERS | |
| 192 | Disability | FAERS: 2 | US FAERS | |
| 193 | Drug ineffective for unapproved indication | FAERS: 2 | US FAERS | |
| 194 | Dystonia | FAERS: 2 | US FAERS | |
| 195 | Ear congestion | FAERS: 2 | US FAERS | |
| 196 | Ecchymosis | FAERS: 2 | US FAERS | |
| 197 | Eczema | FAERS: 2 | US FAERS | |
| 198 | Emergency Care | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 199 | Erectile dysfunction | FAERS: 2 | US FAERS | |
| 200 | Excessive eye blinking | FAERS: 2 | US FAERS | |
| 201 | Expired product administered | FAERS: 2 | US FAERS | |
| 202 | Eye pain | FAERS: 2 | US FAERS | |
| 203 | Facial paralysis | FAERS: 2 | US FAERS | |
| 204 | Flank Pain | FAERS: 2 | US FAERS | |
| 205 | Flatulence | FAERS: 2 | US FAERS | |
| 206 | Gait inability | FAERS: 2 | US FAERS | |
| 207 | Hyperintensity in brain deep nuclei | FAERS: 2 | US FAERS | |
| 208 | Hypertensive crisis | FAERS: 2 | US FAERS | |
| 209 | Incoherent | FAERS: 2 | US FAERS | |
| 210 | Increased upper airway secretion | FAERS: 2 | US FAERS | |
| 211 | Increased ventricular afterload | FAERS: 2 | US FAERS | |
| 212 | Inflammatory marker increased | FAERS: 2 | US FAERS | |
| 213 | Injection related reaction | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 214 | Intelligence test abnormal | FAERS: 2 | US FAERS | |
| 215 | Laryngeal discomfort | FAERS: 2 | US FAERS | |
| 216 | Medication residue present | FAERS: 2 | US FAERS | |
| 217 | Middle insomnia | FAERS: 2 | US FAERS | |
| 218 | Muscle Fatigue | FAERS: 2 | US FAERS | |
| 219 | Muscle Rigidity | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 220 | Myocardial necrosis marker increased | FAERS: 2 | US FAERS | |
| 221 | Myoclonus | FAERS: 2 | US FAERS | |
| 222 | Neuralgia | FAERS: 2 | US FAERS | |
| 223 | Night sweats | FAERS: 2 | US FAERS | |
| 224 | Occupational exposure to product | FAERS: 2 | US FAERS | |
| 225 | Pain of skin | FAERS: 2 | US FAERS | |
| 226 | Piloerection | FAERS: 2 | US FAERS | |
| 227 | Poisoning | FAERS: 2 | US FAERS | |
| 228 | Purpura | FAERS: 2 | US FAERS | |
| 229 | Regurgitation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 230 | Rhinitis | FAERS: 2 | US FAERS | |
| 231 | Secretion discharge | FAERS: 2 | US FAERS | |
| 232 | Skin discomfort | FAERS: 2 | US FAERS | |
| 233 | Skin irritation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 234 | Sputum retention | FAERS: 2 | US FAERS | |
| 235 | Stool heavy metal positive | FAERS: 2 | US FAERS | |
| 236 | Stridor | FAERS: 2 | US FAERS | |
| 237 | Tension | FAERS: 2 | US FAERS | |
| 238 | Thirst | FAERS: 2 | US FAERS | |
| 239 | Tongue discomfort | FAERS: 2 | US FAERS | |
| 240 | Toothache | FAERS: 2 | US FAERS | |
| 241 | Upper respiratory tract inflammation | FAERS: 2 | US FAERS | |
| 242 | VIIth nerve paralysis | FAERS: 2 | US FAERS | |
| 243 | White blood cell count decreased | FAERS: 2 | US FAERS | |
| 244 | Activities of daily living impaired | FAERS: 1 | US FAERS | |
| 245 | Acute kidney injury | FAERS: 1 | US FAERS | |
| 246 | Amnesia | FAERS: 1 | US FAERS | |
| 247 | Anorectal discomfort | FAERS: 1 | US FAERS | |
| 248 | Apparent death | FAERS: 1 | US FAERS | |
| 249 | Arthropathy | FAERS: 1 | US FAERS | |
| 250 | Asthenopia | FAERS: 1 | US FAERS | |
| 251 | Aura | FAERS: 1 | US FAERS | |
| 252 | Back disorder | FAERS: 1 | US FAERS | |
| 253 | Bedridden | FAERS: 1 | US FAERS | |
| 254 | Biliary Colic | FAERS: 1 | US FAERS | |
| 255 | Blighted ovum | FAERS: 1 | US FAERS | |
| 256 | Blindness | FAERS: 1 | US FAERS | |
| 257 | Blood creatinine abnormal | FAERS: 1 | US FAERS | |
| 258 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 259 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 260 | Blood thyroid stimulating hormone decreased | FAERS: 1 | US FAERS | |
| 261 | Bradyphrenia | FAERS: 1 | US FAERS | |
| 262 | Brain Hypoxia | FAERS: 1 | US FAERS | |
| 263 | Capillary Leak Syndrome | FAERS: 1 | US FAERS | |
| 264 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 265 | Central nervous system lesion | FAERS: 1 | US FAERS | |
| 266 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 267 | Cerebral cyst | FAERS: 1 | US FAERS | |
| 268 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 269 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 270 | Cervical cord compression | FAERS: 1 | US FAERS | |
| 271 | Choking | FAERS: 1 | US FAERS | |
| 272 | Chromaturia | FAERS: 1 | US FAERS | |
| 273 | Claustrophobia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 274 | Clonus | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 275 | Colitis | FAERS: 1 | US FAERS | |
| 276 | Completed Suicide | FAERS: 1 | US FAERS | |
| 277 | Contraindicated product administered | FAERS: 1 | US FAERS | |
| 278 | Depressed mood | FAERS: 1 | US FAERS | |
| 279 | Device connection issue | FAERS: 1 | US FAERS | |
| 280 | Diabetic Ketoacidosis | FAERS: 1 | US FAERS | |
| 281 | Diplegia | FAERS: 1 | US FAERS | |
| 282 | Distributive shock | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 283 | Documented hypersensitivity to administered product | FAERS: 1 | US FAERS | |
| 284 | Dose calculation error | FAERS: 1 | US FAERS | |
| 285 | Drug administration error | FAERS: 1 | US FAERS | |
| 286 | Drug clearance decreased | FAERS: 1 | US FAERS | |
| 287 | Drug clearance increased | FAERS: 1 | US FAERS | |
| 288 | Drug effect delayed | FAERS: 1 | US FAERS | |
| 289 | Drug level increased | FAERS: 1 | US FAERS | |
| 290 | Dyspareunia | FAERS: 1 | US FAERS | |
| 291 | Dysuria | FAERS: 1 | US FAERS | |
| 292 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 293 | Electrocardiogram change | FAERS: 1 | US FAERS | |
| 294 | Enuresis | FAERS: 1 | US FAERS | |
| 295 | Epilepsy | FAERS: 1 | US FAERS | |
| 296 | Exophthalmos | FAERS: 1 | US FAERS | |
| 297 | Exposure during breast feeding | FAERS: 1 | US FAERS | |
| 298 | Exposure via direct contact | FAERS: 1 | US FAERS | |
| 299 | Exposure via eye contact | FAERS: 1 | US FAERS | |
| 300 | Facial Paresis | FAERS: 1 | US FAERS | |
| 301 | Failure to Thrive | FAERS: 1 | US FAERS | |
| 302 | Feeling of body temperature change | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 303 | Fibromyalgia | FAERS: 1 | US FAERS | |
| 304 | Fibrosis | FAERS: 1 | US FAERS | |
| 305 | Food Allergy | FAERS: 1 | US FAERS | |
| 306 | Food aversion | FAERS: 1 | US FAERS | |
| 307 | Gastritis | FAERS: 1 | US FAERS | |
| 308 | Gastroenteritis | FAERS: 1 | US FAERS | |
| 309 | Gastrointestinal Pain | FAERS: 1 | SIDER US FAERS | |
| 310 | Gastrointestinal inflammation | FAERS: 1 | US FAERS | |
| 311 | Genital burning sensation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 312 | Hemiparesis | FAERS: 1 | US FAERS | |
| 313 | Hepatitis C | FAERS: 1 | US FAERS | |
| 314 | Hydrocephalus | FAERS: 1 | US FAERS | |
| 315 | Hyperferritinaemia | FAERS: 1 | US FAERS | |
| 316 | Hyporesponsive to stimuli | FAERS: 1 | US FAERS | |
| 317 | Iatrogenic injury | FAERS: 1 | US FAERS | |
| 318 | Idiosyncratic drug reaction | FAERS: 1 | US FAERS | |
| 319 | Immediate post-injection reaction | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 320 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 321 | Impaired quality of life | FAERS: 1 | US FAERS | |
| 322 | Incontinence | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 323 | Increased bronchial secretion | FAERS: 1 | US FAERS | |
| 324 | Infarction | FAERS: 1 | US FAERS | |
| 325 | Infection | FAERS: 1 | SIDER US FAERS | |
| 326 | Injection Site Reaction | FAERS: 1 | US FAERS | |
| 327 | Injection site coldness | FAERS: 1 | US FAERS | |
| 328 | Injection site injury | FAERS: 1 | US FAERS | |
| 329 | Injection site mass | FAERS: 1 | US FAERS | |
| 330 | Injection site phlebitis | FAERS: 1 | US FAERS | |
| 331 | Injection site urticaria | FAERS: 1 | US FAERS | |
| 332 | Injury associated with device | FAERS: 1 | US FAERS | |
| 333 | Laceration | FAERS: 1 | US FAERS | |
| 334 | Limb injury | FAERS: 1 | US FAERS | |
| 335 | Limb mass | FAERS: 1 | US FAERS | |
| 336 | Livedo Reticularis | FAERS: 1 | US FAERS | |
| 337 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 338 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 339 | Lymphangitis | FAERS: 1 | US FAERS | |
| 340 | Macule | FAERS: 1 | US FAERS | |
| 341 | Meningeal disorder | FAERS: 1 | US FAERS | |
| 342 | Mental Fatigue | FAERS: 1 | US FAERS | |
| 343 | Mental status changes | FAERS: 1 | US FAERS | |
| 344 | Mineral supplementation | FAERS: 1 | US FAERS | |
| 345 | Muscle tone disorder | FAERS: 1 | US FAERS | |
| 346 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 347 | Mydriasis | FAERS: 1 | US FAERS | |
| 348 | Myoclonic Epilepsy | FAERS: 1 | US FAERS | |
| 349 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 350 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 351 | Ocular discomfort | FAERS: 1 | US FAERS | |
| 352 | Onychoclasis | FAERS: 1 | US FAERS | |
| 353 | Oral mucosal eruption | FAERS: 1 | US FAERS | |
| 354 | PO2 decreased | FAERS: 1 | US FAERS | |
| 355 | Palmar erythema | FAERS: 1 | US FAERS | |
| 356 | Papule | FAERS: 1 | US FAERS | |
| 357 | Paranasal sinus discomfort | FAERS: 1 | US FAERS | |
| 358 | Paranasal sinus hypersecretion | FAERS: 1 | US FAERS | |
| 359 | Paraplegia | FAERS: 1 | US FAERS | |
| 360 | Paravenous drug administration | FAERS: 1 | US FAERS | |
| 361 | Paresis | FAERS: 1 | US FAERS | |
| 362 | Perseveration | FAERS: 1 | US FAERS | |
| 363 | Personality Change | FAERS: 1 | US FAERS | |
| 364 | Physical disability | FAERS: 1 | US FAERS | |
| 365 | Poor quality drug administered | FAERS: 1 | US FAERS | |
| 366 | Poor quality sleep | FAERS: 1 | US FAERS | |
| 367 | Post procedural swelling | FAERS: 1 | US FAERS | |
| 368 | Procedural nausea | FAERS: 1 | US FAERS | |
| 369 | Product label issue | FAERS: 1 | US FAERS | |
| 370 | Product name confusion | FAERS: 1 | US FAERS | |
| 371 | Product taste abnormal | FAERS: 1 | US FAERS | |
| 372 | Prolonged expiration | FAERS: 1 | US FAERS | |
| 373 | Proteinuria | FAERS: 1 | US FAERS | |
| 374 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 375 | Pulmonary arterial hypertension | FAERS: 1 | US FAERS | |
| 376 | Pulmonary congestion | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 377 | Quadriparesis | FAERS: 1 | US FAERS | |
| 378 | Radial pulse decreased | FAERS: 1 | US FAERS | |
| 379 | Rales | FAERS: 1 | US FAERS | |
| 380 | Reaction to azo-dyes | FAERS: 1 | US FAERS | |
| 381 | Renal Colic | FAERS: 1 | US FAERS | |
| 382 | Respiratory Paralysis | FAERS: 1 | US FAERS | |
| 383 | Retinal Detachment | FAERS: 1 | US FAERS | |
| 384 | Rosacea | FAERS: 1 | US FAERS | |
| 385 | Salt craving | FAERS: 1 | US FAERS | |
| 386 | Scleroderma | FAERS: 1 | US FAERS | |
| 387 | Screaming | FAERS: 1 | US FAERS | |
| 388 | Sensorimotor disorder | FAERS: 1 | US FAERS | |
| 389 | Sepsis | FAERS: 1 | US FAERS | |
| 390 | Shunt occlusion | FAERS: 1 | US FAERS | |
| 391 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 392 | Skin Induration | FAERS: 1 | US FAERS | |
| 393 | Skin Wrinkling | FAERS: 1 | US FAERS | |
| 394 | Skin laceration | FAERS: 1 | US FAERS | |
| 395 | Skin test positive | FAERS: 1 | US FAERS | |
| 396 | Skin texture abnormal | FAERS: 1 | US FAERS | |
| 397 | Slow response to stimuli | FAERS: 1 | US FAERS | |
| 398 | Snoring | FAERS: 1 | US FAERS | |
| 399 | Spinal shock | FAERS: 1 | US FAERS | |
| 400 | Starvation | FAERS: 1 | US FAERS | |
| 401 | Strabismus | FAERS: 1 | US FAERS | |
| 402 | Stress | FAERS: 1 | US FAERS | |
| 403 | Sudden death | FAERS: 1 | US FAERS | |
| 404 | Sunburn | FAERS: 1 | US FAERS | |
| 405 | Suspected counterfeit product | FAERS: 1 | US FAERS | |
| 406 | Swelling of eyelid | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 407 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 408 | Thermoanaesthesia | FAERS: 1 | US FAERS | |
| 409 | Throat clearing | FAERS: 1 | US FAERS | |
| 410 | Thrombosis | FAERS: 1 | US FAERS | |
| 411 | Tongue biting | FAERS: 1 | US FAERS | |
| 412 | Tongue pruritus | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 413 | Transaminases increased | FAERS: 1 | US FAERS | |
| 414 | Trichorrhexis | FAERS: 1 | US FAERS | |
| 415 | Upper respiratory tract congestion | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 416 | Ventricular hypokinesia | FAERS: 1 | US FAERS | |
| 417 | Vessel puncture site reaction | FAERS: 1 | US FAERS | |
| 418 | Visual brightness | FAERS: 1 | US FAERS | |
| 419 | Vulvovaginal dryness | FAERS: 1 | US FAERS | |
| 420 | Wrong drug administered | FAERS: 1 | US FAERS | |
| 421 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 422 | nervous system disorder | FAERS: 1 | US FAERS | |
| 423 | Abnormal vision | SIDER | ||
| 424 | Apathy | SIDER | ||
| 425 | Application site pain | SIDER | ||
| 426 | Breast Feeding | SIDER | ||
| 427 | Dermatitis | SIDER | ||
| 428 | Flat affect | SIDER | ||
| 429 | Glossitis | Canada Vigilance: 1 | Canada Vigilance | |
| 430 | Infusion site pain | Canada Vigilance: 1 | Canada Vigilance | |
| 431 | Infusion site urticaria | Canada Vigilance: 1 | Canada Vigilance | |
| 432 | Instillation site pain | SIDER | ||
| 433 | Pharyngeal swelling | Canada Vigilance: 9 | Canada Vigilance | |
| 434 | Pregnancy | SIDER | ||
| 435 | Stomatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 436 | Vaccination site irritation | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.